Current strategies for myocardial gene delivery

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 5, 2011, Pages 766-776

  Katz, Michael G ^a   Swain, JaBaris D ^a   Tomasulo, Catherine E ^a   Sumaroka, Marina ^a   Fargnoli, Anthony ^a   Bridges, Charles R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiac gene therapy; Cardiopulmonary bypass; Ex vivo perfusion; Gene delivery

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA GALACTOSIDASE; EPSILON SARCOGLYCAN; FIBROBLAST GROWTH FACTOR 4; PARVOVIRUS VECTOR; PLASMID DNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG; VASCULOTROPIN 121;

BIOCOMPATIBILITY; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CELLULAR IMMUNITY; DIRECT GENE DELIVERY; DRUG EFFICACY; ENDOCARDIAL INJECTION; EX VIVO GENE TRANSFER; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEART CATHETERIZATION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; IMMUNE RESPONSE; INTERMETHOD COMPARISON; INTRAMYOCARDIAL INJECTION; INTRAPERICARDIAL INJECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAFETY; TRANSGENE; TRANSVASCULAR GENE DELIVERY; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MYOCARDIUM;

EID: 79953729330     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.09.003     Document Type: Review

References (81)

1. Melo L.G., Pachori A.S., Gnecchi M., Dzau V.J. Genetic therapies for cardiovascular diseases. Trends Mol Med 2005, 11:240-250.
2. Donahue J.K. Gene therapy for cardiac arrhythmias. Ann NY Acad Sci 2004, 1015:332-337.
3. Bernecker O.Y., del Monte F., Hajjar R.J. Gene therapy for the treatment of heart failure-calcium signaling. Semin Thorac Cardiovasc Surg 2003, 15:268-276.
4. Ly H., Kawase Y., Yoneyama R., Hajjar R.J. Gene therapy in the treatment of heart failure. Physiology 2007, 22:81-96.
5. Zhang J.C.L., Woo Y.J., Chen J.A., Swain J.L., Sweeney H.L. Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. J Mol Cell Cardiol 1999, 31:721-732.
6. Fromes Y., Salmon A., Wang X., Collin H., Rouche A., Hagege A., et al. Gene delivery to the myocardium by intrapericardial injection. Gene Ther 1999, 6:683-688.
7. March K.L., Woody M., Mehdi K., Zipes D.P., Brantly M., Trapnell B.C. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999, 22(1):123-129.
8. Lamping K.G., Rios C.D., Chun J.A., Ooboshi H., Davidson B.L., Heistad D.D. Intrapericardial administration of adenovirus for gene transfer. Am J Physiol 1997, 272:H310-H317.
9. Gwon H.C., Jeong J.O., Kim H.J., Park S.W., Lee S.H., Park S.J., et al. The feasibility and safety of fluoroscopy-guided percutaneous intramyocardial gene injection in porcine heart. Int J Cardiol 2001, 79:77-88.
10. Sanborn T.A., Hackett N.R., Lee L.Y., El-Sawy T., Blanco I., Tarazona N., et al. Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Cathet Cardiovasc Intervent 2001, 52:260-266.
11. Vale P.R., Losordo D.W., Tkebuchava T., Chen D., Milliken C.E., Isner J.M. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 1999, 34:246-254.
12. Kornowski R., Leon M.B., Fuchs S., Vodovotz Y., Flynn M.A., Gordon D.A., et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 2000, 35:1031-1039.
13. Sylven C., Sarkar N., Unsulander P., Kennebäck G., Blomberg P., Islam K., et al. Catheter-based transendocardial myocardial gene transfer. J Interv Cardiol 2002, 15:7-13.
14. Grossman P.M., Han Z., Palasis M., Barry J.J., Lederman R.J. Incomplete retention after direct myocardial injection. Cathet Cardiovasc Intervent 2002, 55:392-397.
15. Naimark W.A., Lepore J.J., Klugherz B.D., Wang Z., Guy T.S., Osman H., et al. Adenovirus-catheter compatibility increases gene expression after delivery to porcine myocardium. Hum Gene Ther 2003, 14:161-166.
16. Acsadi G., Jiao S., Jani A., Duke D., Williams P., Chong W., et al. Direct gene transfer and expression into rat heart in vivo. New Biol 1991, 3:71-81.
17. Lin H., Parmacek M.S., Morle G., Bolling S., Leiden J.M. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990, 82:2217-2221.
18. Buttrick P.M., Kass A., Kitsis R.N., Kaplan M.L., Leinwand L.A. Behavior of genes directly injected into the rat heart in vivo. Circ Res 1992, 70:193-198.
19. von Harsdorf R., Schott R.J., Shen Y.T., Vatner S.F., Mahdavi V., Nadal-Ginard B. Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals. Circ Res 1993, 72:688-695.
20. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993, 73:1202-1207.
21. French B.A., Mazur W., Geske R.S., Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994, 90:2414-2424.
22. Magovern C.J., Mack C.A., Zhang J., Hahn R.T., Ko W., Isom O.W., et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg 1996, 62:425-433.
23. Barr E., Carroll J., Kalynych A.M., Tripathy S.K., Kozarsky K., Wilson J.M., et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994, 1:51-58.
24. Svensson E.C., Marshall D.J., Woodard K., Lin H., Jiang F., Chu L., et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 1999, 99:201-205.
25. Tomiyasu K., Oda Y., Nomura M., Satoh E., Fushiki S., Imanishi J., et al. Direct intra-cardiomuscular transfer of β2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters. Gene Ther 2000, 7:2087-2093.
26. Rengo G., Lymperopoulos A., Zincarelli C., Donniacuo M., Soltys S., Rabinowitz J.E., et al. Myocardial adeno-associated virus serotype 6-βARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 2009, 119:89-98.
27. Koransky M.L., Robbins R.C., Blau H.M. VEGF gene delivery for treatment of ischemic cardiovascular disease. Trends Cardiovasc Med 2002, 12:108-114.
28. Edelberg J.M., Huang D.T., Josephson M.E., Rosenberg R.D. Molecular enhancement of porcine cardiac chronotropy. Heart 2001, 86:559-562.
29. Isner J.M., Vale P.R., Symes J.F., Losordo D.W. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001, 89:389-400.
30. Lathi K.G., Vale P.R., Losordo D.W., Cespedes R.M., Symes J.F., Esakof D.D., et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results. Anesth Analg 2001, 92:19-25.
31. Vale P.R., Losordo D.W., Milliken C.E., McDonald M.C., Gravelin L.M., Curry C.M., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001, 103:2138-2143.
32. Losordo D.W., Vale P.R., Symes J., Dunnington C., Esakof D., Maysky M., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98:2800-2804.
33. Rosengart T.K., Lee L.Y., Patel S.R., Kligfield P.D., Okin P.M., Hackett N.R., et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999, 230:466-472.
34. Muhlhauser J., Jones M., Yamada I., Cirielli C., Lemarchand P., Gloe T.R., et al. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther 1996, 3:145-153.
35. Kornowski R., Fuchs S., Leon M.B., Epstein S.E. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 2000, 101:454-458.
36. Hajjar R.J., del Monte F., Matsui T., Rosenzweig A. Prospects for gene therapy for heart failure. Circ Res 2000, 86:616-621.
37. Donahue J.K., Kikkawa K., Johns D.C., Marban E., Lawrence J.H. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci USA 1997, 94:4664-4668.
38. Baker A.H. Development and use of gene transfer for treatment of cardiovascular disease. J Card Surg 2002, 17:543-548.
39. Logeart D., Hatem S.N., Heimburger M., Roux A.L., Michel J.B., Mercadier J.J. How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?. Hum Gene Ther 2001, 12:1601-1610.
40. Hayase M., del Monte F., Kawase Y., MacNeill B.D., McGregor J., Yoneyama R., et al. Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol 2005, 288:H2995-H3000.
41. Kaplitt M.G., Xiao X., Samulski R.J., Li J., Ojamaa K., Klein I.L., et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg 1996, 62:1669-1676.
42. Logeart D., Hatem S.N., R cker-Martin C., Chossat N., Nevo N., Haddada H., et al. Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther 2000, 11:1015-1022.
43. Ding Z., Fach C., Sasse A., Godouble acutedecke A., Schrader J. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther 2004, 11:260-265.
44. Boekstegers P., Kupatt C. Current concepts and applications of coronary venous retroinfusions. Basic Res Cardiol 2004, 99:373-381.
45. Donahue J.K., Kikkawa K., Thomas A.D., Marban E., Lawrence J.H. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther 1998, 5:630-634.
46. Parsa C.J., Reed R.C., Walton G.B., Pascal L.S., Thompson R.B., Petrofski J.A., et al. Catheter-mediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method. J Gene Med 2005, 7:595-603.
47. Wright M.J., Wightman L.M.L., Latchman D.S., Marber M.S. In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther 2001, 8:1833-1839.
48. Emani S.M., Shah A.S., Bowman M.K., Emani S., Wilson K., Glower D.D., et al. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 2003, 8:306-313.
49. Hajjar R.J., Schmidt U., Matsui T., Guerrero J.L., Lee K.H., Gwathmey J.K., et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 1998, 95. 5251-5156.
50. Maurice J.P., Hata J.A., Shah A.S., White D.C., McDonald P.H., Dolber P.C., et al. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery. J Clin Invest 1999, 104:21-29.
51. Parsa C.J., Koch W.J. Gene interventions in the beta-adrenergic system for treating heart failure. Semin Thorac Cardiovasc Surg 2003, 15:259-267.
52. Kaspar B.K., Roth D.M., Lai N.C., Drumm J.D., Erickson D.A., McKirnan M.D., et al. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus. J Gene Med 2005, 7:316-324.
53. Eckhart A.D., Koch W.J. Beta-Adrenergic gene therapy for cardiovascular disease. Curr Control Trials Cardiovasc Med 2000, 1:131-134.
54. Boekstegers P., von Degenfeld G., Giehrl W., Heinrich D., Hullin R., Kupatt C., et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 2000, 7:232-240.
55. Raake P.W., Hinkel R., Muller S., Delker S., Kreuzupointer R., Kupatt C., et al. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 2008, 15:12-17.
56. Hou D., Maclaughlin F., Thiesse M., Panchal V., Bekkers B.C., Wilson E.A., et al. Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Cathet Cardiovasc Intervent 2003, 58:207-211.
57. Kaye D.M., Preovolos A., Marshall T., Burne M., Hoshijima M., Hajjar R., et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007, 50:253-260.
58. Byrne M.J., Power J.M., Preovolos A., Mariani J.A., Hajjar R.J., Kaye D.M. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 2008, 15:1550-1557.
59. Bridges C.R. Recirculating method of cardiac gene delivery should be called "non-recirculating" method. Gene Ther 2009, 16:939-940.
60. Griscelli F., Belli E., Opolon P., Musset K., Connault E., Perricaudet M., et al. Adenovirus-mediated gene transfer to the transplanted piglet heart after intracoronary injection. J Gene Med 2003, 5:109-119.
61. Shah A.S., Lilly E., Kypson A.P., Tai O., Hata J.A., Pippen A., et al. Intracoronary adenovirus-mediated delivery and overexpression of the β2-adrenergic receptor in the heart. Prospects for molecular ventricular assistance. Circulation 2000, 101:408-414.
62. Barr E., Carroll J., Kalynych A.M., Tripathy S.K., Kozarsky K., Wilson J.M., et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994, 1:51-58.
63. Donahue J.K., Heldman A.W., Fraser H., McDonald A.D., Miller J.M., Rade J.J., et al. Focal modifications of electrical conduction in the heart by viral gene transfer. Nat Med 2000, 6:1395-1398.
64. White D.C., Milano C.A. Gene therapy in cardiovascular disease: state of the art. Ann Surg 2003, 238:S90-S99.
65. Lee J., Laks H., Drinkwater D.C., Blitz A., Lam L., Shiraishi Y., et al. Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thorac Cardiovasc Surg 1996, 111:246-252.
66. Kypson A.P., Peppel K., Akhter S.A., Lilly R.E., Glower D.D., Lefkowitz R.J., et al. Ex vivo adenovirus-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg 1998, 115:623-630.
67. Wang J.Y.M., Knechtle S.J. Adenovirus-mediated gene transfer into rat cardiac allografts: comparison of direct injection and perfusion. Transplantation 1996, 61:1726-1729.
68. Gojo S., Niwaya K., Taniguchi S., Nishizaki K., Kitamura S. Gene transfer into the donor heart during cold preservation for heart transplantation. Ann Thorac Surg 1998, 65:647-652.
69. Shah A.S., White D.C., Tai O., Hata J.A., Wilson K.H., Pippen A., et al. Adenovirus-mediated genetic manipulation of the myocardial β-adrenergic signaling system in transplanted hearts. J Thorac Cardiovasc Surg 2000, 120:581-588.
70. Bridges C.R., Burkman J.M., Malekan R., Konig S.M., Chen H., Yarnall C.B., et al. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg 2002, 73:1939-1946.
71. Davidson M.J., Jones J.M., Emani S.M., Wilson K.H., Jaggers J., Koch W.J., et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001, 104:131-133.
72. Jones J.M., Wilson K.H., Koch W.J., Milano C.A. Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression. Eur J Cardiothorac Surg 2002, 21:847-852.
73. Jones J.M., Koch W.J. Gene therapy approaches to cardiovascular disease. Methods Mol Med 2005, 112:15-35.
74. Ikeda Y., Gu Y., Iwanada Y., Hoshijima M., Oh S.S., Giordano F.J., et al. Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation 2002, 105:502-508.
75. Bridges C.R., Gopal K., Holt D.E., Yarnall C., Cole S., Anderson R.B., et al. Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 2005, 130:1364-1370.
76. Vinge L.E., Raake P.W., Koch W.J. Gene therapy in heart failure. Circ Res 2008, 102:1458-1470.
77. Rosengart T.K., Lee L.Y., Patel S.R., Sanborn T.A., Parikh M., Bergman G.W., et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEFG 121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999, 100:468-474.
78. Vale P.R., Losordo D.W., Milliken C.E., McDonald M.C., Gravelin L.M., Curry C.M., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001, 103:2138-2143.
79. Grines C.L., Watkins M.W., Helmer G., Penny W., Brinker J., Marmur J.D., et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002, 105:1291-1297.
80. Hajjar R.J., Zsebo K., Deckelbaum L., Thompson C., Rudy J., Yaroshinsky A., et al. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail 2008, 14:355-367.
81. Jaski B.E., Jessup M.L., Mancini D.M., Cappola T.P., Pauly D.F., Greenberg B., et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 2009, 15:171-181.